CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Non-Controlling Interest [Member]	Total
Balance at beginning at Dec. 31, 2017	$ 479	$ 38	$ 36,918,132	$ (23,414,151)	$ 4,503,046	$ 780,737	$ 18,788,281
Balance at beginning (in shares) at Dec. 31, 2017	478,776	37,778
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense due to stock option issuances			426,873				426,873
Compensation expense due to warrant issuances			46,954				46,954
Issuance of common stock for services		$ 3	3,758,293				3,758,296
Issuance of common stock for services (in shares)		3,354
Issuance of common stock and warrants for cash		$ 24	18,551,565				18,551,589
Issuance of common stock and warrants for cash (in shares)		23,821
Issuance of common stock for conversion of debt		$ 3	2,167,841				2,167,844
Issuance of common stock for conversion of debt (in shares)		2,538
Issuance of common stock for conversion of short-term advances		$ 4	2,819,580				2,819,584
Issuance of common stock for conversion of short-term advances (in shares)		4,540
Issuance of common stock upon exercise of stock options			97,800				97,800
Issuance of common stock upon exercise of stock options (in shares)		75
Issuance of common stock upon exercise of warrants		$ 3	867,163				867,166
Issuance of common stock upon exercise of warrants (in shares)		2,682
Issuance of Series B preferred stock for conversion of short-term advances	$ 25		249,975				250,000
Issuance of Series B preferred stock for conversion of short-term advances (in shares)	25,000
Issuance of common stock for conversion of Series E preferred stock	$ (379)	$ 1	378
Issuance of common stock for conversion of Series E preferred stock (in shares)	(378,776)	947
Issuance of common stock in connection with convertible notes		$ 1	675,220				675,221
Issuance of common stock in connection with convertible notes (in shares)		1,362
Repurchase of common stock			(55,000)				(55,000)
Repurchase of common stock (in shares)		(69)
Beneficial conversion feature in connection with convertible notes			288,573				288,573
Fair value of warrants issued in connection with convertible notes			3,408,665				3,408,665
Cash for exchange fees and other financing costs			(1,838,013)				(1,838,013)
Non-controlling interest from acquisition of I. AM						33,242	33,242
Comprehensive loss:
Net loss				(12,948,403)			(12,948,403)
Preferred deemed dividends			108,049	(108,049)
Net unrealized gain on securities available-for-sale, net of income taxes					(5,445,925)		(5,445,925)
Foreign currency translation adjustments				(81,786)	(131,849)		(131,849)
Net loss attributable to non-controlling interest						(144,080)	(144,080)
Balance at end at Jun. 30, 2018	$ 125	$ 77	68,492,048	(36,552,389)	(1,074,728)	669,899	31,535,032
Balance at end (in shares) at Jun. 30, 2018	125,000	77,028
Balance at beginning at Dec. 31, 2017	$ 479	$ 38	36,918,132	(23,414,151)	4,503,046	780,737	18,788,281
Balance at beginning (in shares) at Dec. 31, 2017	478,776	37,778
Balance at end at Dec. 31, 2018	$ 126	$ 101	77,647,544	(55,721,115)	(3,902,523)	40,658	18,064,791
Balance at end (in shares) at Dec. 31, 2018	126,434	100,910
Balance at beginning at Mar. 31, 2018	$ 225	$ 53	50,772,786	(29,474,673)	(211,611)	745,306	21,832,086
Balance at beginning (in shares) at Mar. 31, 2018	224,276	52,544
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense due to stock option issuances			194,019				194,019
Compensation expense due to warrant issuances			23,477				23,477
Issuance of common stock for services		$ 1	724,999				725,000
Issuance of common stock for services (in shares)		1,250
Issuance of common stock and warrants for cash		$ 18	12,308,216				12,308,234
Issuance of common stock and warrants for cash (in shares)		17,420
Issuance of common stock for conversion of short-term advances		$ 4	2,819,580				2,819,584
Issuance of common stock for conversion of short-term advances (in shares)		4,540
Issuance of common stock upon exercise of warrants		$ 1	(1)
Issuance of common stock upon exercise of warrants (in shares)		349
Issuance of Series B preferred stock for conversion of short-term advances	$ 25		249,975				250,000
Issuance of Series B preferred stock for conversion of short-term advances (in shares)	25,000
Issuance of common stock for conversion of Series E preferred stock	$ (125)		125
Issuance of common stock for conversion of Series E preferred stock (in shares)	(124,276)	311
Issuance of common stock in connection with convertible notes			321,548				321,548
Issuance of common stock in connection with convertible notes (in shares)		683
Repurchase of common stock			(55,000)				(55,000)
Repurchase of common stock (in shares)		(69)
Fair value of warrants issued in connection with convertible notes			2,003,617				2,003,617
Cash for exchange fees and other financing costs			(979,342)				(979,342)
Non-controlling interest from acquisition of I. AM						33,242	33,242
Comprehensive loss:
Net loss				(6,887,881)			(6,887,881)
Preferred deemed dividends			108,049	(108,049)
Net unrealized gain on securities available-for-sale, net of income taxes					(704,811)		(704,811)
Foreign currency translation adjustments				(81,786)	(158,306)		(158,306)
Net loss attributable to non-controlling interest						(108,649)	(108,649)
Balance at end at Jun. 30, 2018	$ 125	$ 77	68,492,048	(36,552,389)	(1,074,728)	669,899	31,535,032
Balance at end (in shares) at Jun. 30, 2018	125,000	77,028
Balance at beginning at Dec. 31, 2018	$ 126	$ 101	77,647,544	(55,721,115)	(3,902,523)	40,658	18,064,791
Balance at beginning (in shares) at Dec. 31, 2018	126,434	100,910
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense due to stock option issuances			493,954				493,954
Issuance of common stock for cash		$ 192	5,453,552				5,453,744
Issuance of common stock for cash (in shares)		191,179
Issuance of common stock for services		$ 9	253,010				253,019
Issuance of common stock for services (in shares)		9,375
Issuance of common stock in payment of accrued liabilities		$ 9	108,514				108,523
Issuance of common stock in payment of accrued liabilities (in shares)		9,375
Issuance of common stock for conversion of debt		$ 26	2,608,431				2,608,458
Issuance of common stock for conversion of debt (in shares)		26,402
Issuance of common stock upon exercise of warrants		$ 700	6,620,325				6,621,025
Issuance of common stock upon exercise of warrants (in shares)		699,887
Issuance of Series A preferred stock for cash	$ 6		140,144				140,150
Issuance of Series A preferred stock for cash (in shares)	5,606
Beneficial conversion feature in connection with convertible notes			188,448				188,448
Fair value of warrants issued in connection with convertible notes			58,448				58,448
Cash for exchange fees and other financing costs			(1,195,004)				(1,195,004)
Comprehensive loss:
Net loss				(10,737,507)			(10,737,507)
Preferred dividends				(7,153)			(7,153)
Net unrealized gain (loss) on derivatives in related party					(361,181)		(361,181)
Foreign currency translation adjustments					192,505		192,505
Net loss attributable to non-controlling interest						(32,416)	(32,416)
Balance at end at Jun. 30, 2019	$ 132	$ 1,037	92,377,366	(66,465,775)	(4,071,199)	8,242	21,849,803
Balance at end (in shares) at Jun. 30, 2019	132,040	1,037,128
Balance at beginning at Mar. 31, 2019	$ 126	$ 231	84,903,648	(62,401,594)	(4,478,216)	8,242	18,032,437
Balance at beginning (in shares) at Mar. 31, 2019	126,504	231,478
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Compensation expense due to stock option issuances			248,340				248,340
Issuance of common stock for cash		$ 97	1,056,112				1,056,209
Issuance of common stock for cash (in shares)		96,388
Issuance of common stock in payment of accrued liabilities		$ 9	108,514				108,523
Issuance of common stock in payment of accrued liabilities (in shares)		9,375
Issuance of common stock upon exercise of warrants		$ 700	6,620,325				6,621,025
Issuance of common stock upon exercise of warrants (in shares)		699,887
Issuance of Series A preferred stock for cash	$ 6		138,394				138,400
Issuance of Series A preferred stock for cash (in shares)	5,536
Beneficial conversion feature in connection with convertible notes			188,448				188,448
Fair value of warrants issued in connection with convertible notes			58,448				58,448
Cash for exchange fees and other financing costs			(944,863)				(944,863)
Comprehensive loss:
Net loss				(4,058,897)			(4,058,897)
Preferred dividends				(5,284)			(5,284)
Net unrealized gain (loss) on derivatives in related party					375,499		375,499
Foreign currency translation adjustments					31,518		162,648
Net loss attributable to non-controlling interest
Balance at end at Jun. 30, 2019	$ 132	$ 1,037	$ 92,377,366	$ (66,465,775)	$ (4,071,199)	$ 8,242	$ 21,849,803
Balance at end (in shares) at Jun. 30, 2019	132,040	1,037,128